Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries Ltd.

By: via Benzinga
In a report published Friday, Sterne Agee analyst Shibani Malhotra reiterated a Neutral rating and $53.00 price target on Teva ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.